REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 3	2026-02-24		NCT06650579

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Emory University	393
National Cancer Institute (NCI)	3015
National Comprehensive Cancer Network	27
Pfizer	431
Sumitomo Pharma America, Inc.	16

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Emory Proton Therapy Center	Atlanta	United States	30
Emory Saint Joseph's Hospital	Atlanta	United States	175
Emory University Hospital/Winship Cancer Institute	Atlanta	United States	299
Winship at Emory Midtown	Atlanta	United States	1